Article

NeurologyLive® Brain Games: June 11, 2023

Author(s):

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is Parkinson disease and related disorders.

Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.

Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.

This week's questions include the theme of Parkinson disease and related disorders.

Click here to check out the prior iterations of Brain Games.

Interested in submitting quiz questions? Contact our associate editorial director, Matt Hoffman, via email: mhoffman@neurologylive.com.

Levodopa-carbidopa has been established as the gold standard therapy for patients with Parkinson disease. However, it is not a perfect treatment, and is often accompanied by initial adverse effects, which may include which of the following (select all that apply).


Several genes have been definitively linked to PD, including SNCA, LRRK2, DJ-1, and PRKN, as well as which other?


There are 4 primary symptoms of PD, including tremors, rigidity, and postural instability. What is the fourth?


How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!

How many questions did you get correct?

One
Two
Three

Related Videos
Gil Rabinovici, MD
MaryAnn Mays, MD
Henri Ford, MD, MHA
Michael Levy, MD, PhD, is featured in this series.
David A. Hafler, MD, FANA
© 2024 MJH Life Sciences

All rights reserved.